![Jim Connolly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jim Connolly
Director/Board Member at
VALNEVA SE
Net worth: 51 563 $ as of 2026-06-29
Profile
James Edward Connolly currently works at Covenant House, Inc., as Director, Valneva SE, as Independent Director from 2023, and International AIDS Vaccine Initiative, Inc., as Director from 2011.
Mr. Connolly also formerly worked at Tivorsan Pharmaceuticals, Inc., as Chief Executive Officer & Director from 2015 to 2020, Emergent Travel Health, Inc., as Director from 2014 to 2018, Pivotal Therapeutics, Inc., as Director in 2014, Ambulatus Robotics, Inc., as Director from 2020 to 2021, Aeras Global TB Vaccine Foundation, as Director in 2013, Vaxess Technologies, Inc., as Director from 2013 to 2019, Wyeth Pharmaceuticals LLC, as Executive Vice President & General Manager, and Wyeth Canada ULC, as President.
Mr. Connolly received his undergraduate degree from Washington University in St. Louis.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
VALNEVA SE 0.01% | 2025-12-30 | 20,000 ( 0.01% ) | 51 563 $ | 2026-06-29 |
Jim Connolly active positions
| Companies | Position | Start |
|---|---|---|
| VALNEVA SE | Director/Board Member | 2022-06-23 |
Covenant House, Inc. | Director/Board Member | - |
International AIDS Vaccine Initiative, Inc.
 International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops vaccines for AIDS | Director/Board Member | 2010-12-31 |
Former positions of Jim Connolly
| Companies | Position | End |
|---|---|---|
Ambulatus Robotics, Inc. | Director/Board Member | 2021-01-01 |
Tivorsan Pharmaceuticals, Inc.
 Tivorsan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics for the treatment of neuromuscular disorders | Chief Executive Officer | 2019-12-31 |
Vaxess Technologies, Inc.
 Vaxess Technologies, Inc. BiotechnologyHealth Technology Develops therapies for oncology care and infectious diseases | Director/Board Member | 2018-12-31 |
Emergent Travel Health, Inc.
 Emergent Travel Health, Inc. BiotechnologyHealth Technology Provides biotechnical research services | Director/Board Member | 2018-09-30 |
| PIVOTAL THERAPEUTICS INC. | Director/Board Member | 2014-04-22 |
Training of Jim Connolly
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
71
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Washington University in St. Louis
 Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets infant pharmaceutical products | Health Technology |
Aeras Global TB Vaccine Foundation
 Aeras Global TB Vaccine Foundation Miscellaneous Commercial ServicesCommercial Services Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD. | Commercial Services |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops vaccines for AIDS | Health Technology |
Emergent Travel Health, Inc.
Emergent Travel Health, Inc. BiotechnologyHealth Technology Provides biotechnical research services | Health Technology |
Pivotal Therapeutics, Inc.
 Pivotal Therapeutics, Inc. Financial ConglomeratesFinance Operates as a specialty pharmaceutical company | Finance |
Vaxess Technologies, Inc.
Vaxess Technologies, Inc. BiotechnologyHealth Technology Develops therapies for oncology care and infectious diseases | Health Technology |
Wyeth Canada ULC
 Wyeth Canada ULC Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Covenant House, Inc. | |
Valneva SE
 Valneva SE BiotechnologyHealth Technology Develops and commercializes of prophylactic vaccines for infectious diseases | Health Technology |
Tivorsan Pharmaceuticals, Inc.
Tivorsan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics for the treatment of neuromuscular disorders | Health Technology |
Ambulatus Robotics, Inc. |
- Stock Market
- Insiders
- Jim Connolly
